BioCentury | Aug 20, 2020
Management Tracks

Shao out as Sorrento CFO; plus changes at Kronos, Rome and Alveo

Sorrento Therapeutics Inc. (NASDAQ:SRNE) terminated Jiong Shao as EVP and CFO. He is succeeded as CFO by Najjam Asghar, who is the company’s chief accounting officer. Sorrento did not give a reason for its decision. The company...
BioCentury | Jul 20, 2018
Company News

Management tracks: Merck KGaA, Aeglea

Merck KGaA (Xetra:MRK) hired Maria Rivas as SVP, head of global medical affairs. She was SVP, head of medical affairs at Merck & Co. Inc. (NYSE:MRK). Enzyme therapy company Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) said interim...
BioCentury | Feb 20, 2012
Company News

SQI Diagnostics, Integrated Sciences Pty. Ltd. sales and marketing update

...SQI granted Integrated Sciences exclusive rights to market SQI's IVD products in Australia, including its quantitative IgX...
...Celiac kits and SQiDworks platform. Details were not disclosed. SQI Diagnostics Inc. (TSX-V:SQD), Toronto, Ontario Integrated Sciences Pty. Ltd....
BioCentury | Feb 13, 2006
Company News

NuGen, Integrated Sciences Pty., MJS BioLynx Inc. sales and marketing update

...NuGen granted Integrated Sciences rights to distribute nucleic acid amplification and labeling systems in Australia. MJS received...
...MJS received Canadian rights to the NuGen products. NuGen Technologies Inc. , San Carlos, Calif. Integrated Sciences Pty. Ltd....
BioCentury | Oct 17, 2000
Financial News

Millennium sells overallotment

MLNM raised $93.8 million through the sale of 1.5 million shares at $64 per share authorized to cover overallotments in its October follow-on. The sale brings to $797.8 million the total raised in the deal,...
Items per page:
1 - 5 of 5
BioCentury | Aug 20, 2020
Management Tracks

Shao out as Sorrento CFO; plus changes at Kronos, Rome and Alveo

Sorrento Therapeutics Inc. (NASDAQ:SRNE) terminated Jiong Shao as EVP and CFO. He is succeeded as CFO by Najjam Asghar, who is the company’s chief accounting officer. Sorrento did not give a reason for its decision. The company...
BioCentury | Jul 20, 2018
Company News

Management tracks: Merck KGaA, Aeglea

Merck KGaA (Xetra:MRK) hired Maria Rivas as SVP, head of global medical affairs. She was SVP, head of medical affairs at Merck & Co. Inc. (NYSE:MRK). Enzyme therapy company Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) said interim...
BioCentury | Feb 20, 2012
Company News

SQI Diagnostics, Integrated Sciences Pty. Ltd. sales and marketing update

...SQI granted Integrated Sciences exclusive rights to market SQI's IVD products in Australia, including its quantitative IgX...
...Celiac kits and SQiDworks platform. Details were not disclosed. SQI Diagnostics Inc. (TSX-V:SQD), Toronto, Ontario Integrated Sciences Pty. Ltd....
BioCentury | Feb 13, 2006
Company News

NuGen, Integrated Sciences Pty., MJS BioLynx Inc. sales and marketing update

...NuGen granted Integrated Sciences rights to distribute nucleic acid amplification and labeling systems in Australia. MJS received...
...MJS received Canadian rights to the NuGen products. NuGen Technologies Inc. , San Carlos, Calif. Integrated Sciences Pty. Ltd....
BioCentury | Oct 17, 2000
Financial News

Millennium sells overallotment

MLNM raised $93.8 million through the sale of 1.5 million shares at $64 per share authorized to cover overallotments in its October follow-on. The sale brings to $797.8 million the total raised in the deal,...
Items per page:
1 - 5 of 5